AzTrials
AzTrials

Wheel Spoke InjuryNCT07377708

Platelet-Rich Plasma Versus Saline Dressings in Pediatric Heel Pad Injuries

A study testing Autologous Platelet-Rich Plasma (PRP) Dressing and Normal Saline Dressings in people with Wheel Spoke Injury and Heel Pad Injuries, run by Services Institute of Medical Sciences, Pakistan at 1 site in Pakistan.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study is testing whether autologous platelet rich plasma (PRP) dressings are more effective than normal saline dressings in treating heel pad injuries caused by motorcycle wheel spokes among children in Pakistan. Read more about this study

Who is it for?
Ages 5 to 12 years
What is being tested?
Autologous Platelet-Rich Plasma (PRP) Dressing and Normal Saline Dressings
Could I receive a placebo?
No, everyone receives an active treatment
How many people
60 participants
Where
1 sitePakistan
Study dates
16 Apr 2024to 30 Apr 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 5 to 12 years
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • Children aged 5-12 years
  • Both genders
  • Presenting with heel pad injuries caused by motorcycle wheel-spoke trauma

Who cannot join

  • Children with wounds older than 3 weeks
  • Children with wounds resulting from comorbidities

Trial locations and contacts

1 site in 1 country.

Pakistan1 site
  • Services Hospital Lahore

    Lahore, Punjab Province

Other trials in Pakistan

About this study

Official title: A Comparison of Autologous Platelet-Rich Plasma Dressing Versus Saline Dressing in the Management of Pediatric Heel Pad Injuries Due to Motorcycle Wheel-Spoke Trauma

This study is testing whether autologous platelet rich plasma (PRP) dressings are more effective than normal saline dressings in treating heel pad injuries caused by motorcycle wheel spokes among children in Pakistan. PRP is prepared from a child's own blood and contains natural growth factors that may help wounds to heal faster. The study compares healing rates, reduction in wound size, and time to complete wound healing between the platelet-rich plasma and saline dressing groups.

Read the detailed description

Motorcycle wheel-spoke injuries occur when the heel or foot becomes entrapped in the spokes of a moving motorcycle, frequently resulting in severe soft tissue damage in children. Healing of these injuries is often prolonged and challenging. Platelet-rich plasma (PRP), prepared from a patient's own blood, contains a high concentration of growth factors that promote tissue regeneration, angiogenesis, and wound contraction. Previous studies in adults with diabetic and chronic ulcers have demonstrated that PRP may accelerate wound healing compared with conventional dressings.

However, evidence supporting the use of PRP in the pediatric population, particularly for heel pad injuries resulting from motorcycle wheel-spoke trauma, remains limited. This randomized controlled trial is designed to evaluate the efficacy of platelet-rich plasma dressing compared with saline dressing in children aged 5 to 12 years presenting with heel pad injuries.

A total of 60 participants will be enrolled and randomly assigned to receive either platelet-rich plasma dressing or saline dressing. Study outcomes will include wound healing within 12 weeks, duration of wound healing in days, and changes in wound size measured in both longitudinal and horizontal dimensions. This trial aims to generate evidence for a more effective and locally feasible wound management strategy for pediatric heel pad injuries in the study setting.

Being tested
Autologous Platelet-Rich Plasma (PRP) Dressing, Normal Saline Dressings
Keywords
Platelet Rich Plasma (PRP), Saline Dressing, Wound Care Trauma - Pediatric, Motorcycle Injuries, Soft Tissue Repair, Pediatric Surgery

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Autologous Platelet-Rich Plasma (PRP) DressingBiological

    Approximately 10 mL of venous blood is processed in the pathology department to prepare PRP, which is applied as a wound dressing. Dressings are applied over ~4 weeks, with outpatient follow-up until 12 weeks.

  • Normal Saline DressingsOther

    Conventional sterile normal saline dressings are applied over ~4 weeks, with outpatient follow-up until 12 weeks.

Study groups in NCT07377708
Study groupRoleWhat they receive
Autologous Platelet-Rich Plasma DressingsExperimentalApproximately 10 mL of venous blood is processed to prepare PRP, which is applied as a wound dressing for 3 days. Applied for about 4 weeks, with follow-up until 12 weeks.
Receives: Biological: Autologous Platelet-Rich Plasma (PRP) Dressing
Normal Saline DressingActive comparatorConventional sterile saline dressings are applied daily over ~4 weeks, with follow-up until 12 weeks.
Receives: Other: Normal Saline Dressings

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Wound Healing Status

    Wound status based on presence of granulation tissue and measurement of wound size.

    Measured: Up to 12 weeks

Secondary outcomes (3)
  1. Duration of healing

    Number of days from baseline until there is no further change in wound size.

    Measured: Up to 12 weeks

  2. Percentage Change in Longitudinal Wound Dimension

    Calculated as (baseline longitudinal size - size at 12 weeks) ÷ baseline longitudinal size × 100.

    Measured: 12 weeks

  3. Percentage Change in Horizontal Wound Dimension

    Calculated as (baseline horizontal size-sizeat12weeks)÷base line horizontal size X 100

    Measured: 12 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted30 Jan 2026
  2. Study start16 Apr 2024
  3. Primary completion30 Apr 2025
  4. Study completion30 Apr 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
Two-arm randomized controlled trial, 1:1 allocation by lottery method (PRP dressing vs normal saline dressing).
Masking
None (open label)
Enrolment
60 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07377708
Sponsor's protocol ID
IRB/2023/1091/SIMS
Status last verified
Jan 2026
First submitted
22 Jan 2026
Last updated
2 Feb 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: Individual participant data collected in this study will not be shared outside the study team to protect participant privacy and in accordance with local regulations.

Publications

  • Somani A, Rai R. Comparison of Efficacy of Autologous Platelet-rich Fibrin versus Saline Dressing in Chronic Venous Leg Ulcers: A Randomised Controlled Trial. J Cutan Aesthet Surg. 2017 Jan-Mar;10(1):8-12. doi: 10.4103/JCAS.JCAS_137_16.

    PubMed 28529414
  • Elsaid A, El-Said M, Emile S, Youssef M, Khafagy W, Elshobaky A. Randomized Controlled Trial on Autologous Platelet-Rich Plasma Versus Saline Dressing in Treatment of Non-healing Diabetic Foot Ulcers. World J Surg. 2020 Apr;44(4):1294-1301. doi: 10.1007/s00268-019-05316-0.

    PubMed 31811339

Questions about this trial

What is this clinical trial studying?

A study testing Autologous Platelet-Rich Plasma (PRP) Dressing and Normal Saline Dressings in people with Wheel Spoke Injury and Heel Pad Injuries, run by Services Institute of Medical Sciences, Pakistan at 1 site in Pakistan.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 2 Feb 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Pakistan. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Wound Healing Status (time frame: Up to 12 weeks). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07377708, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 Feb 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in